United States· US:0270-0556_0d2aa8b3-2d00-f50a-c4cc-92748288e6aa

KINEVAC

A sincalide product containing sincalide, registered in United States by Bracco Diagnostics Inc.. The same ATC class is registered in 3 of our 19 countries.

ATC V04CC03

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedKINEVACATCV04CC03REGISTER NO.US:0270-0556_0d2aa8b3…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Sincalide is registered in 3 of 19 countries.

Countries holding a registration under ATC V04CC03 (sincalide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose

Sincalide · ATC V04CC03

3 / 19 countries

  • Canada
  • Finlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SINCALIDE
Manufacturer
Bracco Diagnostics Inc.
Country
United States (US)
ATC code
V04CC03
ATC class
Sincalide
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0270055615
    10 VIAL in 1 PACKAGE (0270-0556-15) / 5 mL in 1 VIAL
  • ndc11
    0270-0556-15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sincalide in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sincalide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/11b8224a-645c-4ed8-9ec7-fdbfaeb3ede0
GET /v1/drugs/11b8224a-645c-4ed8-9ec7-fdbfaeb3ede0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "5",
  "substance": "SINCALIDE",
  "productndc": "0270-0556",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "ug/5mL",
  "application_number": "NDA017697",
  "marketing_category": "NDA"
}

See everything about sincalide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.